$RGBP Desmond, Earlier today I went to the Molecu
Post# of 373
"Scientific Advisory Board
Harry Lander, Ph.D., MBA
Dr. Lander previously served as interim CEO of MVAX from January 01, 2016 to April 30, 2016 to assist Mr. Dixon with BORIS licensing agreement. Dr. Lander has voluntarily resigned to take the helm of our Scientific Advisory Board.
Dr. Lander has over 20 years of professional scientific, business and financial management experience related to biomedical research. Dr. Lander has extensive relationships with large and small biotechnology / pharmacology companies and entities that MolecuVax expects to leverage for company growth. Dr. Lander is currently President of Regen BioPharma, Inc. a publicly traded biotechnology company. Formerly he has served as Research Chief / Administration for Sidra Medical and Research Center (Doha, Qatar) and Assistant Provost for Weill Cornell Medical College (Cornell University)."
Source: http://molecuvax.com/?page_id=149